Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OK Study: Lopinavir/ritonavir Monotherapy vs Triple Therapy in HIV
NCT00114933Phase 4Completed
- Start
- Jan 2005
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV). Primary endpoint: Percentage of patients with therapeutic failure at 48 weeks. Started Jan 2005; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00114933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114933.